{
  "trial_id": "NCT04170491",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patients aged > 16 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Consent obtained according to Mental Capacity Act 2005",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Convulsive Status epilepticus defined by either: Tonic-clonic SE lasting longer than 5 minutes,",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Status epilepticus that continues despite treatment with benzodiazepine and one antiepileptic medication",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Anoxic brain injury",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Other exclusion criteria not mentioned in the patient's history",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of severe intellectual disability, CHF, and epilepsy. He presented with facial twitching and generalized shaking, which required valium to cease seizure activity.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT04170491",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}